The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Vitebskaia A.V.

FGU Éndokrinologicheskiĭ nauchnyĭ tsentr, Moskva

Petriaĭkina E.E.

Morozovskaia detskaia gorodskaia klinicheskaia bol'nitsa

Razumovsky A.Yu.

Subdepartment of Pediatric Surgery of the N.I. Pirogov Russian National Research Medical University under the Ministry of Health of the Russia, Moscow, Russia, 117997

Pavlov A.A.

Detskaia gorodskaia klinicheskaia bol'nitsa #13 im. N.F. Filatova, Moskva

Tiul'pakov A.N.

Éndokrinologicheskiĭ nauchnyĭ tsentr, Moskva

A case of severe neonatal hyperparathyroidism due to defect in calcium receptors

Authors:

Vitebskaia A.V., Petriaĭkina E.E., Razumovsky A.Yu., Pavlov A.A., Tiul'pakov A.N.

More about the authors

Journal: Problems of Endocrinology. 2010;56(4): 27‑33

Read: 1390 times


To cite this article:

Vitebskaia AV, Petriaĭkina EE, Razumovsky AYu, Pavlov AA, Tiul'pakov AN. A case of severe neonatal hyperparathyroidism due to defect in calcium receptors. Problems of Endocrinology. 2010;56(4):27‑33. (In Russ.)

References:

  1. D'Souza-Li L., Yang B., Canaff L. et al. Identification and functional characterization of novel calcium-sensing receptor mutations in familial hypocalciuric hypercalcemia and autosomal dominant hypocalcemia. J Clin Endocrinol Metab 2002; 87: 3: 1309-1318.
  2. Hebert S.C. Extracellular calcium-sensing receptor: implications for calcium and magnesium handling in the kidney. Kidney. Int 1996; 50: 6: 2129-2139
  3. Hauache O.M. Extracellular calcium-sensing receptor: structural and functional features and association with diseases. Braz J Med Biol Res 2001; 34: 5: 577-584.
  4. Den Dunnen J.T., Antonarakis E. Nomenclature for the description of human sequence variations. Hum Genet 2001; 109: 121-124.
  5. Ward B.K., Magno A.L., Davis E.A. et al. Functional Deletion of the Calcium-Sensing Receptor in a Case of Neonatal Severe Hyperparathyroidism. J Clin Endocrinol Metab 2004; 89: 8: 3721-3730.
  6. Pearce S., Steinmann B. Casting new light on the clinical spectrum of neonatal severe hyperparathyroidism. Clin Endocrinol (Oxf) 1999; 50: 691-693.
  7. Garrett J.E., Capuano I.V., Hammerland L.G. et al. Molecular cloning and functional expression of human parathyroid calcium receptor cDNA. J Biol Chem 1995; 270: 12919-12925.
  8. Rukovodstvo po detskoi endokrinologii. Pod red I.I. Dedova, V.A. Peterkovoi. M: Universum pablishing 2006; 600.
  9. MakDermott M.T. Sekrety endokrinologii. Per. s angl. M: BINOM 1998; 416.
  10. Marx S.J., Fraser D., Rapoport A. Familial hypocalciuric hypercalcemia: mild expression of the gene in heterozygotes and severe expression in homozygotes. Am J Med 1985; 78: 1: 15-22.
  11. Aida K., Koishi S., Inoue M. et al. Familial hypocalciuric hypercalcemia associated with mutation in the human Ca2+-sensing receptor gene. J Clin Endocrinol Metab 1995; 80: 9: 2594-2598.
  12. Harris S.S., D'Ercole A.J. Neonatal hyperparathyroidism: the natural course in the absence of surgical intervention. Pediatrics 1989; 83: 1: 53-56.
  13. Bai M., Pearce S.H., Kifor O. et al. In vivo and in vitro characterization of neonatal hyperparathyroidism resulting from a de novo, heterozygous mutation in the Ca2+-sensing receptor gene: normal maternal calcium homeostasis as a cause of secondary hyperparathyroidism in familial benign hypocalciuric hypercalcemia. J Clin Invest 1997; 99: 1: 88-96.
  14. Marx S.J., Attie M.F., Levine M.A. et al. The hypocalciuric or benign variant of familial hypercalcemia: clinical and biochemical features in fifteen kindreds. Medicine 1981; 60: 6: 397-412.
  15. Brown E.M., MacLeod R.J. Extracellular calcium sensing and extracellular calcium signaling. Physiol Rev 2001; 81: 239-297.
  16. Law W.M. Jr., Heath H.D. Familial benign hypercalcemia (hypocalciuric hypercalcemia): clinical and pathogenetic studies in 21 families. Ann Intern Med 1985; 102: 4: 511-519.
  17. Pollak M.R., Chou Y.H., Marx S.J. et al. Familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism: effect of mutant gene dosage on phenotype. J Clin Invest 1994; 93: 3: 1108-1112.
  18. Kobayashi M., Tanaka H., Tsuzuki K. et al. Two novel missense mutations in calcium-sensing receptor gene associated with neonatal severe hyperparathyroidism. J Clin Endocrinol Metab 1997; 82: 8: 2716-2719.
  19. Carling T., Szabo E., Bai M. et al. Familial hypercalcemia and hypercalciuria caused by a novel mutation in the cytoplasmic tail of the calcium receptor. J Clin Endocrinol Metab 2000; 85: 5: 2042-2047.
  20. Pidasheva S., D'Souza-Li L., Canaff L. et al. CASRdb: calcium-sensing receptor locus-specific database for mutations causing familial (benign) hypocalciuric hypercalcemia, neonatal severe hyperparathyroidism, and autosomal dominant hypocalcemia. Hum Mutat 2004; 24: 2: 107-111.
  21. Pollak M.R., Brown E.M., Chou Y.H. et al. Mutations in the human Ca(2+)-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Cell 1993; 75: 7: 1297-1303.
  22. Silve C., Petrel C., Leroy C. et al. Delineating a Ca2+ binding pocket within the venus flytrap module of the human calcium-sensing receptor. J Biol Chem 2005; 280: 45: 37917-37923.
  23. Hendy G.N., D'Souza-Li L., Yang B. et al. Mutations of the calcium-sensing receptor (CASR) in familial hypocalciuric hypercalcemia, neonatal severe hyperparathyroidism, and autosomal dominant hypocalcemia. Hum Mutat 2000; 16: 4: 281-296.
  24. Hu J., McLarnon S.J., Mora S. et al. A region in the seven-transmembrane domain of the human Ca2+ receptor critical for response to Ca2+. J Biol Chem 2005; 280: 6: 5113-5120.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.